An investigation by the Maryland Department of Health and Mental Hygiene confirmed that an isotope contamination case was an isolated incident (see link below). What was extraordinary was the way local and state agencies put the pieces of the puzzle together.
Health officials in one Maryland county's communicable disease unit were notified on Nov. 12, 2004, about a case of acute hepatitis C. During an interview, the patient mentioned knowing someone similarly diagnosed at a different hospital. Their spouses worked together, and the two had met Oct. 15 at a clinic for a nuclear stress test, according to the DHMH report released on Monday.
An examination of clinic records revealed a third person whose hep C was reported to the county on Nov. 11. Coincidence was beginning to seem unlikely, according to the report. A further scrutiny of records showed that the three patients with confirmed hepatitis - and five others tested at the clinic on Oct. 15 - had been injected with doses of technetium-99m-labeled sestamibi prepared from the same pharmacy.
As the investigation focused on the pharmacy, the DHMH sent statewide alerts, requesting prompt entry of cases into the Maryland Electronic Reporting and Surveillance System. No other cases resulted from this effort. The DHMH and the Centers for Disease Control and Prevention began testing employees at the clinic and the pharmacy. These tests were negative.
Local and state officials expanded their investigation to other clinics that had received doses of the radionuclide drawn from the same lot number. In all, 16 cases in three different counties were found. An analysis of potential risk factors occurring at the time of incubation found individual cases of blood transfusion, renal dialysis, and surgery. But the only true commonality was that each had received a cardiac stress test on Oct. 15, 2004.
The pharmacy investigation revealed a number of procedural practices that could result in cross-contamination. A review of the records showed that the donor of labeled leukocytes, compounded on Oct. 15, had previously been diagnosed with hepatitis C. Genetic testing further revealed the donor's viral RNA to be genotype 1a, which matched 12 of 16 outbreak cases where the viral genotype could be determined.
Because of the time lag of a month between infection and initial outbreak, physical evidence at the pharmacy was minimal. Nonetheless, officials pieced together a convincing picture of the likelihood of the source of contamination.
The fact that the first patient interviewed by the DHMH could tell officials about a friend similarly diagnosed was a lucky stroke. After that, however, the investigation proceeded deliberately, with good coordination between the various governmental agencies, follow-up of leads, and analysis along the way of the available evidence.
For more information from the Diagnostic Imaging archives:
Contaminated radioisotopes cause hepatitis C infections
Comment: Serendipity and footwork each play a role in investigation
An investigation by the Maryland Department of Health and Mental Hygiene confirmed that an isotope contamination case was an isolated incident (see link below). What was extraordinary was the way local and state agencies put the pieces of the puzzle together.
An investigation by the Maryland Department of Health and Mental Hygiene confirmed that an isotope contamination case was an isolated incident (see link below). What was extraordinary was the way local and state agencies put the pieces of the puzzle together.
Health officials in one Maryland county's communicable disease unit were notified on Nov. 12, 2004, about a case of acute hepatitis C. During an interview, the patient mentioned knowing someone similarly diagnosed at a different hospital. Their spouses worked together, and the two had met Oct. 15 at a clinic for a nuclear stress test, according to the DHMH report released on Monday.
An examination of clinic records revealed a third person whose hep C was reported to the county on Nov. 11. Coincidence was beginning to seem unlikely, according to the report. A further scrutiny of records showed that the three patients with confirmed hepatitis - and five others tested at the clinic on Oct. 15 - had been injected with doses of technetium-99m-labeled sestamibi prepared from the same pharmacy.
As the investigation focused on the pharmacy, the DHMH sent statewide alerts, requesting prompt entry of cases into the Maryland Electronic Reporting and Surveillance System. No other cases resulted from this effort. The DHMH and the Centers for Disease Control and Prevention began testing employees at the clinic and the pharmacy. These tests were negative.
Local and state officials expanded their investigation to other clinics that had received doses of the radionuclide drawn from the same lot number. In all, 16 cases in three different counties were found. An analysis of potential risk factors occurring at the time of incubation found individual cases of blood transfusion, renal dialysis, and surgery. But the only true commonality was that each had received a cardiac stress test on Oct. 15, 2004.
The pharmacy investigation revealed a number of procedural practices that could result in cross-contamination. A review of the records showed that the donor of labeled leukocytes, compounded on Oct. 15, had previously been diagnosed with hepatitis C. Genetic testing further revealed the donor's viral RNA to be genotype 1a, which matched 12 of 16 outbreak cases where the viral genotype could be determined.
Because of the time lag of a month between infection and initial outbreak, physical evidence at the pharmacy was minimal. Nonetheless, officials pieced together a convincing picture of the likelihood of the source of contamination.
The fact that the first patient interviewed by the DHMH could tell officials about a friend similarly diagnosed was a lucky stroke. After that, however, the investigation proceeded deliberately, with good coordination between the various governmental agencies, follow-up of leads, and analysis along the way of the available evidence.
For more information from the Diagnostic Imaging archives:
Contaminated radioisotopes cause hepatitis C infections
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3
September 1st 2023In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.
FDA Clears New 7T MRI System from Siemens Healthineers
March 27th 2024Offering improved image clarity capable of capturing details of subtle pathology, the Magnetom Terra.X 7T MRI system reportedly features the first eight-channel parallel transmit architecture for clinical use.
The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2
August 23rd 2023In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.
Ultrasound Nomogram May Enhance Prediction of Metastatic Axillary Lymph Nodes in Breast Cancer Patients
March 27th 2024A nomogram that combines contrast-enhanced lymphatic ultrasound and grayscale ultrasound findings had an 88 percent AUC for prediction of three or more metastatic axillary lymph nodes in women with early breast cancer.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3
September 1st 2023In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.
FDA Clears New 7T MRI System from Siemens Healthineers
March 27th 2024Offering improved image clarity capable of capturing details of subtle pathology, the Magnetom Terra.X 7T MRI system reportedly features the first eight-channel parallel transmit architecture for clinical use.
The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2
August 23rd 2023In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.
Ultrasound Nomogram May Enhance Prediction of Metastatic Axillary Lymph Nodes in Breast Cancer Patients
March 27th 2024A nomogram that combines contrast-enhanced lymphatic ultrasound and grayscale ultrasound findings had an 88 percent AUC for prediction of three or more metastatic axillary lymph nodes in women with early breast cancer.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.